Literature DB >> 28757906

Lumbosacral Dorsal Rhizotomy for Spastic Cerebral Palsy: A Health Technology Assessment.

.   

Abstract

BACKGROUND: Cerebral palsy, a spectrum of neuromuscular conditions caused by abnormal brain development or early damage to the brain, is the most common cause of childhood physical disability. Lumbosacral dorsal rhizotomy is a neurosurgical procedure that permanently decreases spasticity and is always followed by physical therapy. The objectives of this health technology assessment were to evaluate the clinical effectiveness, safety, cost effectiveness, and family perspectives of dorsal rhizotomy.
METHODS: We performed a systematic literature search until December 2015 with auto-alerts until December 2016. Search strategies were developed by medical librarians, and a single reviewer reviewed the abstracts. The health technology assessment included a clinical review based on functional outcomes, safety, and treatment satisfaction; an economic study reviewing cost-effective literature; a budget impact analysis; and interviews with families evaluating the intervention.
RESULTS: Eighty-four studies (1 meta-analysis, 5 randomized controlled studies [RCTs], 75 observational pre-post studies, and 3 case reports) were reviewed. A meta-analysis of RCTs involving dorsal rhizotomy and physical therapy versus physical therapy confirmed reduced lower-limb spasticity and increased gross motor function (4.5%, P = .002). Observational studies reported statistically significant improvements in gross motor function over 2 years or less (12 studies, GRADE moderate) and over more than 2 years (10 studies, GRADE moderate) as well as improvements in functional independence in the short term (10 studies, GRADE moderate) and long term (4 studies, GRADE low). Major operative complications, were infrequently reported (4 studies). Bony abnormalities and instabilities monitored radiologically in the spine (15 studies) and hip (8 studies) involved minimal or clinically insignificant changes after surgery. No studies evaluated the cost effectiveness of dorsal rhizotomy. The budget impact of funding dorsal rhizotomy for treatment of Ontario children with cerebral palsy was $1.3 million per year. Families reported perceived improvements in their children and expressed satisfaction with treatment. Ontario families reported inadequate medical information on benefits or risk to make an informed decision, enormous financial burdens, and lack rehabilitation support after surgery.
CONCLUSIONS: Lumbrosacral dorsal rhizotomy and physical therapy effectively reduces lower-limb spasticity in children with spastic cerebral palsy and significantly improves their gross motor function and functional independence. Major peri-operative complications were infrequently reported. Families reported perceived improvements with dorsal rhizotomy, and surgery and post-operative rehabilitation were intensive and demanding.

Entities:  

Mesh:

Year:  2017        PMID: 28757906      PMCID: PMC5515320     

Source DB:  PubMed          Journal:  Ont Health Technol Assess Ser        ISSN: 1915-7398


  276 in total

1.  Development and validation of item sets to improve efficiency of administration of the 66-item Gross Motor Function Measure in children with cerebral palsy.

Authors:  Dianne J Russell; Lisa M Avery; Stephen D Walter; Steven E Hanna; Doreen J Bartlett; Peter L Rosenbaum; Robert J Palisano; Jan Willem Gorter
Journal:  Dev Med Child Neurol       Date:  2009-10-07       Impact factor: 5.449

Review 2.  A clinical overview of treatment decisions in the management of spasticity.

Authors:  M E Gormley; C F O'Brien; S A Yablon
Journal:  Muscle Nerve Suppl       Date:  1997

3.  Effects of cognitive, motor, and sensory disabilities on survival in cerebral palsy.

Authors:  J L Hutton; P O Pharoah
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

4.  Long-term results of posterior functional rhizotomy.

Authors:  V A Fasano; G Broggi; S Zeme; G Lo Russo; A Sguazzi
Journal:  Acta Neurochir Suppl (Wien)       Date:  1980

5.  Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy.

Authors:  Kristina Tedroff; Kristina Löwing; Dan N O Jacobson; Eva Åström
Journal:  Dev Med Child Neurol       Date:  2011-05-18       Impact factor: 5.449

6.  Recent trends in cerebral palsy survival. Part I: period and cohort effects.

Authors:  Jordan C Brooks; David J Strauss; Robert M Shavelle; Linh M Tran; Lewis Rosenbloom; Yvonne W Wu
Journal:  Dev Med Child Neurol       Date:  2014-06-26       Impact factor: 5.449

7.  Inclusion of the S2 dorsal rootlets in functional posterior rhizotomy for spasticity in children with cerebral palsy.

Authors:  F F Lang; V Deletis; H W Cohen; L Velasquez; R Abbott
Journal:  Neurosurgery       Date:  1994-05       Impact factor: 4.654

8.  Effects of deep brain stimulation in dyskinetic cerebral palsy: a meta-analysis.

Authors:  Anne Koy; Martin Hellmich; K Amande M Pauls; Warren Marks; Jean-Pierre Lin; Oliver Fricke; Lars Timmermann
Journal:  Mov Disord       Date:  2013-02-13       Impact factor: 10.338

9.  Selective dorsal rhizotomy as an alternative to intrathecal baclofen pump replacement in GMFCS grades 4 and 5 children.

Authors:  Harshal Ingale; Ismail Ughratdar; Samiul Muquit; Ahmad A Moussa; Michael H Vloeberghs
Journal:  Childs Nerv Syst       Date:  2015-11-09       Impact factor: 1.475

10.  Long-term outcomes five years after selective dorsal rhizotomy.

Authors:  Eva Nordmark; Annika Lundkvist Josenby; Jan Lagergren; Gert Andersson; Lars-Göran Strömblad; Lena Westbom
Journal:  BMC Pediatr       Date:  2008-12-14       Impact factor: 2.125

View more
  3 in total

1.  Improving access to selective dorsal rhizotomy for children with cerebral palsy.

Authors:  Benjamin Davidson; Darcy Fehlings; Golda Milo-Manson; George M Ibrahim
Journal:  CMAJ       Date:  2019-11-04       Impact factor: 8.262

Review 2.  Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-11-02

Review 3.  Muscle architecture, growth, and biological Remodelling in cerebral palsy: a narrative review.

Authors:  Geoffrey G Handsfield; Sîan Williams; Stephanie Khuu; Glen Lichtwark; N Susan Stott
Journal:  BMC Musculoskelet Disord       Date:  2022-03-10       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.